Sheila Mikhail's most recent trade in Verve Therapeutics Inc was a trade of 42,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Sheila Mikhail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 42,200 | 42,200 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Sheila Mikhail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 136,139 | 136,139 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Sheila Mikhail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,642 | 26,642 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Sheila Mikhail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 15,500 | 15,500 | - | - | Stock Option (right to buy) |